Published on 2 Nov 2022 on Zacks via Yahoo Finance
Top Research Reports for Abbott Laboratories, ServiceNow & Schlumberger
Wednesday, November 2, 2022The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), ServiceNow, Inc. (NOW) and Schlumberger Ltd. (SLB). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Abbott Laboratories’ shares have declined -22.2% over the past year against the Zacks Medical - Products industry’s decline of -49.3%. The company’s total sales were negatively impacted by COVID-19 testing-related sales decline and a manufacturing stoppage initiated in February of certain infant nutrition formula products manufactured at Abbott's Sturgis, MI, facility.Excluding these negative factors, total worldwide sales increased 6% on an organic basis, benefiting from robust sales growth across the company’s core Established Pharmaceuticals and Medical Devices segments.Meanwhile, the Diabetes Care business continued to benefit from the growing sales of its flagship CGM system, FreeStyle Libre. Abbott exited the third quarter of 2022 with better-than-expected earnings and revenues. The raised 2022 guidance buoys optimism.(You can read the full research report on Abbott Laboratories here >>>)Shares of ServiceNow have underperformed the Zacks Computers - IT Services industry over the past year (-39.1% vs. -35.3%). The company is suffering from high inflation, unfavorable forex and challenging macro-economic environment. Stiff competition is a headwind and is expected to hurt prospects in the long haul.However, robust growth in subscription revenues as reflected by the strong third-quarter 2022 results. The company is riding on the increasing adoption of its workflows by enterprises undergoing digital transformation. As businesses, government agencies and others continue to their infrastructure to cloud, the company is poised to boost uptake of its Now platform.Further, its expanding global presence, solid partner base and strategic buyouts are expected to bolster growth prospects. Strategic alliances with the likes of Microsoft remain tailwinds.(You can read the full research report on ServiceNow here >>>)Schlumberger’s shares have outperformed the Zacks Oil and Gas - Field Services industry over the past year (+56.3% vs. +6.4%). The company is the largest oilfield services player, with a presence in every energy market across the globe. Being the leading provider of technology for complex oilfields, the company is well-poised to take up new offshore projects in international markets.The significant increase in oil prices is aiding its overall business. Increased participation in growth of drilling and completion activities across the world brightened the company’s outlook. Schlumberger reported strong third-quarter results owing to strong activities in land and offshore resources in North America and Latin America.However, the company’s balance sheet has massive debt exposure compared with the composite stocks in the industry. Also, the aggressive capital spending budget remains a headwind for the company. As such, the stock warrants a cautious stance.(You can read the full research report on Schlumberger here >>>)Other noteworthy reports we are featuring today include Archer-Daniels-Midland Co. (ADM), Shopify Inc. (SHOP), and Workday, Inc. (WDAY).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Story continues
Today's Must Read